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Abstract
 
Intestinal lamina propria T lymphocytes (LP-Ts) have a markedly low proliferative potential
both in vivo and in vitro. Here, we have identified that the capacity of antigen-presenting
cells to release cysteine upon receptor–ligand interactions represents a critical parameter for
proliferation of LP-Ts. The availability of cysteine is limiting for the intracellular production
of glutathione, which in turn is essential for cell cycle progression. When cysteine is provided
either directly or by addition of the reducing agent 2-mercaptoethanol to cystine-containing
culture medium, proliferation of LP-T is fully restored. Importantly, coculture with periph-
eral blood monocytes that easily take up cystine, reduce cystine, and secrete cysteine also re-
stores reactivity of LP-Ts to T cell receptor/CD3 stimulation. In marked contrast, lamina
propria macrophages lack this capacity to elaborate cysteine, and thereby secure physiological
unresponsiveness to antigen exposure in the intestinal microenvironment. The well-docu-
mented local recruitment of blood monocytes in inflammatory bowel disease (IBD) may thus
represent an important parameter underlying hyperresponsiveness of T cells, an essential com-
ponent of the pathogenesis of IBD.
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Introduction
 
Human intestinal lamina propria T lymphocytes (LP-Ts) do
usually not develop systemic immune responses despite a per-
manent exposure to foreign bacterial and nutritional antigens.
When compared with peripheral blood T lymphocytes, the
reactivity of LP-Ts to in vitro stimulation by mitogenic CD3
antibodies is reduced (1), whereas experimental activation
through the costimulatory receptors CD2 or CD28 is similar
(1, 2). Mechanisms maintaining this “altered” state of respon-
siveness in the normal gut as well as the increased reactivity of
LP-Ts to TCR/CD3 engagement in chronic inflammatory
bowel disease (IBD) are unclear. Several hypotheses have
been put forward, such as continuous antigenic stimulation
that would lock LP-Ts in a hyporesponsive state (3), local
production of antiinflammatory IL-10 (4), and impaired co-
stimulation by lamina propria macrophages (LP-MOs [5]). In
addition, low molecular weight nonprotein mediators with
oxidative capacities produced in the gut mucosa have been
proposed to be involved in descreased antigen-mediated
stimulation of LP-Ts (6). Therefore, the balance of naturally
occurring redoxactive substances in the microenvironment
might regulate the reactivity of LP-Ts.
In this study, we provide evidence for a dominant role of
thiol-mediated redoxregulation for intestinal T lymphocyte
reactivity. Cysteine is the limiting substrate for the synthesis
of glutathione, which is a prerequisite for cell cycle pro-
gression (7). Cysteine, but not equimolar amounts of cys-
tine, and 2-ME (which acts by improving cellular uptake of
cysteine [8]) fully restore CD3 reactivity of LP-Ts. Periph-
eral blood monocytes (PB-MOs) support the proliferation
of T cells by release of cysteine that is triggered by CD2–
CD58 interactions, whereas in contrast, LP-MOs lack this
ability. Because PB-MOs infiltrate the inflamed gut in
IBD, cysteine release by PB-MOs evolves as a novel mech-
anism of lymphocyte stimulation likely to be relevant to
the pathogenesis of IBD.
 
Materials and Methods
 
mAbs and Reagents.
 
The following mouse mAbs were affinity
purified from tissue culture supernatant on protein A sepharose
(Amersham Pharmacia Biotech): M1 (anti-CD2; IgG1), M2 (anti-
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CD2; IgG1), 3PT (anti-CD2; IgG2a), OKT3 (anti-CD3; IgG2a),
1A3 (anti-CD58; IgG2a), GP89 (anti-CD54; IgG2a). OKT3 (1
 
m
 
g/ml) was immobilized on immunobeads (10
 
8
 
/ml) coated with
goat anti–mouse Ig (Irvine Scientific) for 2 h at 37
 
8
 
C in PBS/0.5%
BSA. Recombinant human IL-2 was a gift from Biotest. 1,3-Bis(2-
chloroethyl)-1-nitrosourea (BCNU) was purchased from Bristol
Laboratories and dissolved in ethanol. Buthionine-
 
S
 
,
 
R
 
,-sulfox-
imine (BSO), 5,5
 
9
 
-dithio-bis(2-nitrobenzoic acid) (DTNB), LPS
from 
 
Escherichia coli
 
 (serotype 055:B5), 2-ME, dithiothreitol (DTT),
glutathione disulfide (GSSG), and hydrogen peroxide were ob-
tained from Sigma-Aldrich, and cystine was obtained from GIBCO
BRL. Dissolved cysteine (Serva) and reduced glutathione (GSH;
Serva) were adjusted to pH 7.3 before use.
 
Preparation of Cells from Intestinal Lamina Propria and Peripheral
Blood.
 
Normal colon mucosa was obtained from patients undergo-
ing resection for colon cancer. LP-Ts were isolated according to a
modified method of Bull and Bookman (9) as described earlier (1),
with the exception that the mucus was scraped off with a scalpel
instead of incubating the tissue with the antioxidant DTT. In
brief, the tissue was washed in HBSS without Ca
 
2
 
1
 
 or Mg
 
2
 
1 
 
and cut
into 2–4-mm pieces, and epithelial cells were removed by incubation
with EDTA. After enzymatic digestion (collagenase, deoxyribonu-
clease I), viable mononuclear cells were obtained by Percoll and sub-
sequent Ficoll-Hypaque density gradient centrifugation. Cells were
resuspended in a 1:1 mixture of RPMI 1640/2% FCS and autolo-
gous serum, and were allowed to adhere to plastic Petri dishes for 3 h
at 37
 
8
 
C. Adherent cells were harvested using a rubber policeman,
and were used as LP-MOs. LP-Ts were purified from nonadherent
cells by E-rosette formation with SRBC (ICN Biomedicals [6]), and
were 90% positive for CD3. PBMCs from the same patient were iso-
lated by Ficoll-Hypaque density gradient centrifugation. Cells adher-
ent to plastic Petri dishes were used as PB-MOs. All cells were finally
resuspended in RPMI 1640 plus 10% FCS, penicillin/streptomycin,
and 2% glutamine. In some experiments, cystine-deficient RPMI
1640 was used (Serva/BioWhittaker).
 
Proliferation Assay.
 
LP-Ts (5 
 
3
 
 10
 
4
 
/well) were cultured in
96-well round-bottomed microtiter plates (Costar) at 37
 
8
 
C and
7% CO
 
2
 
. Cells were stimulated via CD3 using OKT3-coated
beads (ratio beads/cells 
 
5 
 
4:1), or via CD2 using the mitogenic
mAb M1
 
1
 
M2 (1 
 
m
 
g/ml each) plus 3PT (0.33 
 
m
 
g/ml). PB-MOs
and LP-MOs were irradiated (50 Gy) before use, and were added
to LP-Ts at 30% of total cell number. Wells were pulsed with 1
 
m
 
Ci [
 
3
 
H]-TdR (Amersham Pharmacia Biotech) at day 4 for 16 h,
and then were harvested on glass fiber filters using an automatic
cell harvester (FilterMate; Packard Instrument Co.). [
 
3
 
H]-TdR
uptake was measured in a microplate scintillation counter (Top-
Count; Packard Instrument Co.). Results are expressed as mean
cpm of triplicate cultures 
 
6
 
 SD.
 
Determination of Acid-soluble Thiol.
 
Cysteine was determined as
acid-soluble thiol essentially as described earlier (10). The cell-free
supernatant (600 
 
m
 
l) was mixed with 150 
 
m
 
l EDTA (80 mM) and
150 
 
m
 
l TCA (30%) to precipitate protein. After incubation for 15
min on ice and centrifugation, the supernatant (267 
 
m
 
l) was mixed
with 400 
 
m
 
l phosphate buffer (0.5 M; pH 7.0) and 100 
 
m
 
l NaOH
(1 N). Finally, 33 
 
m
 
l DTNB (10 mM) was added, and increase of
the absorption was measured at 412 nm using cysteine as a standard.
 
Results
 
Influence of Oxidants and Antioxidants on DNA Synthesis
of LP-Ts.
 
Micromolar concentrations of hydrogen per-
oxide suppressed activation of LP-T via CD3 or CD2
 
(Fig. 1 A). Similarly, specific inhibition of the enzyme
glutathione reductase by BCNU (11), leading to accu-
mulation of oxidized glutathione, as well as specific in-
hibition of glutathione synthesis by BSO (12), abolished
proliferation of LP-Ts. On the contrary, the reducing
thiol compound 2-ME potentiated activation at concen-
trations as low as 5–10 
 
m
 
M. The antioxidant DTT en-
hanced proliferation reaching peak values at 0.5 mM and
1 mM for CD3 and CD2 stimulation, respectively (data
not shown). Shifting the redox milieu from a prooxidant
to a more antioxidative state restored proliferation again
(Fig. 1 B): addition of 2-ME was able to counteract the
suppression of T cell proliferation induced by hydrogen
peroxide or BSO.
 
Evidence for a Redox-based Mechanism of Costimulation of
LP-Ts by PB-MOs but Not LP-MOs.
 
The proliferation of
LP-Ts after stimulation with OKT3 alone was considerably
enhanced by the addition of PB-MOs (Fig. 2 A). This co-
stimulatory effect of PB-MOs increased up to 30% of total
cell number. Similar results were obtained after CD2 stim-
ulation. However, LP-MOs failed to support the prolifera-
tion of LP-Ts. The antioxidant 2-ME (10 
 
m
 
M) fully re-
Figure 1. Redoxregulation of DNA synthesis in LP-Ts. (A) Influence
of antioxidative (2-ME) and prooxidant (hydrogen peroxide, BSO,
BCNU) culture conditions on the proliferation of LP-Ts after CD3 (10
U/ml IL-2 added) or CD2 stimulation. (B) Protective effect of 2-ME on
the hydrogen peroxide or BSO-induced suppression of proliferation. 
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stored the CD3 reactivity of LP-T without any costimulus:
proliferation was equivalent to cultures containing PB-
MOs and LP-Ts (Fig. 2 B). Note that LP-MOs did not ac-
tively suppress proliferation. 2-ME enhances T lymphocyte
proliferation by increasing uptake of cysteine derived from
cystine (8), thus compensating for the low membrane
transport activity of lymphocytes for cystine (10, 13).
However, monocytes/macrophages readily take up cystine
which, after intracellular reduction, is secreted as cysteine
(14, 15). Thus, the proliferation of LP-T is subject to thiol-
mediated redoxregulation, and release of reducing equiva-
lents by PB-MOs but not by LP-MOs could be relevant
for costimulation of LP-Ts. This view is supported by the
fact that coculture of LP-Ts with PB-MOs abolished the
suppressive effect of hydrogen peroxide, whereas LP-MOs
completely lacked this capacity (Fig. 3).
 
PB-MO–mediated Costimulation of LP-Ts Involves CD2–
CD58 Interaction.
 
Does the redox-mediated costimulation
of LP-Ts by PB-MOs involve receptor–ligand interactions?
CD2–CD58 interactions could be a candidate, as the ex-
pression of CD58 is known to markedly differ between
PB-MOs and LP-MOs (5). Disruption of CD2–CD58 in-
teractions by saturating concentrations of the blocking
CD58 mAb 1A3 (10 
 
m
 
g/ml) reduced the costimulatory ef-
fect of PB-MOs by 63% when proliferation of LP-Ts was
induced by M1
 
1
 
M2 mAb (Fig. 4). The inhibitory action
of 1A3 was on PB-MOs and not on lymphocytes, as stimu-
lation induced by the mitogenic combination of the CD2
mAb M1
 
1
 
M2
 
1
 
3PT was not influenced by 1A3.
 
Cross-linking of CD58 on PB-MOs, but not on LP-MOs,
Induces Release of Cysteine.
 
We next explored the effect of
CD58 cross-linking on thiol release by PB-MOs. To this
end, PB-MOs (5 
 
3
 
 10
 
5
 
/ml) were added to wells that were
precoated with the CD58 mAb 1A3 (IgG2a). Release of
cysteine was measured as acid-soluble thiol in the superna-
tant after 40 h of culture. All of the acid-soluble thiol in the
supernatant could be defined as cysteine when analyzed by
HPLC (16), and no GSH was detectable (data not shown).
As shown in Fig. 5 A, PB-MOs constitutively released mi-
cromolar amounts of cysteine. Cross-linking of CD58 en-
hanced production three- to fourfold, equivalent to stimu-
lation with LPS (1 
 
m
 
g/ml), whereas a CD54 mAb (Fig. 5
A) or an isotype-matched control antibody (not shown)
were ineffective. Interestingly, IFN-
 
g
 
 (200 U/ml), a potent
activator of PB-MOs, failed to enhance cysteine produc-
tion in both unstimulated (Fig. 5 A) and LPS-treated PB-
MOs (not shown). Note that LP-MOs did not release any
cysteine into the supernatant, neither constitutively nor af-
ter activation with LPS or cross-linking of CD58 (Fig. 5
A). 2-ME (25 
 
m
 
M), inhibition of glutathione synthesis by
BSO (25 
 
m
 
M), hydrogen peroxide (50 
 
m
 
M), and BCNU
(25 
 
m
 
M) did not affect thiol production by PB-MOs (Fig.
5 B), suggesting that a redox system other than GSH/
GSSG is involved in intracellular reduction of cystine to
cysteine in PB-MOs.
Figure 2. Costimulation of LP-Ts by PB-MOs or 2-ME, but not by
LP-MOs. (A) Irradiated LP-MOs or autologous PB-MOs were added to
LP-Ts (5 3 104/well) in graded amounts up to 30% of total cell number.
(B) Costimulatory potential of 2-ME in comparison with irradiated PB-
MOs and LP-MOs (30% of total cell number). unstim., unstimulated.
Figure 3. Protective effect of PB-MOs versus LP-MOs on the suppres-
sion of proliferation of LP-Ts by hydrogen peroxide, which was added at
the beginning of the culture. unstim., unstimulated. 
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Thiol-mediated Redoxregulation of LP-Ts by PB-MOs.
 
In
contrast to lymphocytes, monocytes/macrophages have a
high membrane transport activity for cystine (14). After in-
tracellular reduction of cystine, exported cysteine is taken
up by T cells (10, 14, 15, 17). It follows that costimulation
of LP-Ts by PB-MOs (see Fig. 2) should be strictly depen-
dent on the availability of cystine. Indeed, as shown in Fig.
6 A, the costimulatory potential of PB-MOs (or 2-ME) de-
clined with decreasing concentrations of cystine.
If PB-MOs costimulate proliferation of LP-Ts by release
of cysteine, then (in the absence of PB-MOs) supplementa-
tion of cysteine should result in a higher proliferation rate
than equimolar amounts of cystine. To test this hypothesis,
cystine-free cultures of LP-Ts were supplemented with ei-
ther 30 
 
m
 
M cysteine or equimolar amounts of cystine (15
 
m
 
M 
 
5 
 
30 
 
m
 
M cysteine equivalents) every 6 h. Repetitive
applications were necessary because cysteine is rapidly oxi-
dized in culture to cystine with a half-life of 
 
z
 
1 h. Although
the cumulative cystine concentration was 255 
 
m
 
M (510 
 
m
 
M
cysteine equivalents) at termination of the culture, the pres-
ence of only 30 
 
m
 
M cysteine was far superior (Fig. 6 B).
Transport of cysteine to lymphocytes is the limiting step in
maintaining a critical intracellular GSH concentration (10,
17), which is crucial for cell cycle progression (7). As shown
in Table I, supplementation of cystine-free cultures with
GSH (3 mM) in the absence of PB-MOs could restore pro-
liferation as well. Equimolar amounts of oxidized glutathione
(1.5 mM GSSG) were without effect.
 
Discussion
 
Proliferation of T cells from the human intestinal lamina
propria is subject to thiol-mediated redox regulation. No
proliferation was observed in thiol-deficient culture me-
dium, but it could be restored by supplementation with
cysteine, which was far superior to supplementation with
equimolar amounts of its oxidized form, cystine. In lym-
phocytes, cysteine is the limiting substrate for the synthesis
of GSH (10, 17). T lymphocytes have a strong transport ac-
tivity for cysteine (10, 13), but this is of only limited use,
because cysteine circulates at very low concentrations (
 
z
 
10
 
m
 
M [16]). The plasma concentration of cystine is much
higher (140 
 
m
 
M cysteine equivalents), but the membrane
transport activity for cystine in human lymphocytes is
 
.
 
10-fold lower than for cysteine (10, 13). GSH is essential
for cell cycle progression, as GSH depletion in human PB-
MCs has been shown to inhibit transition from G
 
1
 
 to S
phase (7). Accordingly, proliferation of LP-Ts is inhibited
in the presence of BSO and, conversely, the abortive CD3
and CD2 stimulation of LP-Ts in cystine-deficient medium
is fully restored by administration of GSH. Antioxidative
cellular redox conditions support lymphocyte proliferation,
as we have shown with the use of 2-ME, DTT, and GSH,
whereas prooxidant conditions in the presence of hydrogen
Figure 4. Involvement of CD2–CD58 interactions in PB-MO–medi-
ated costimulation of LP-Ts. CD58 mAb (1A3) was used at saturating
concentrations (10 mg/ml). Irradiated PB-MOs were added at 30% of to-
tal cell number. The dotted line indicates the baseline as defined by the
proliferation induced by the CD2 mAb M11M2.
Figure 5. (A) Release of cysteine (acid-soluble thiol) by PB-MOs ver-
sus LP-MOs after 40 h of culture. Cells were plated at 5 3 105/ml in a
total volume of 1 ml/well in 48-well culture plates, and were either left
untreated or activated with LPS or IFN-g. For cross-linking of CD58
and CD54, wells were precoated with 1A3 and GP89 mAb, respectively,
at 10 mg/ml in PBS for 2 h at 378C followed by two washes with PBS/5%
FCS. Data represent one of three independent experiments performed
with identical results. (B) Effect of 2-ME, hydrogen peroxide, BSO,
and BCNU, respectively, on release of cysteine (acid-soluble thiol) by
PB-MOs. 
911
 
Sido et al. Brief Definitive Report
 
peroxide, BSO, and BCNU inhibit DNA synthesis. Alter-
ations of the intracellular redox balance profoundly affect
early signal transduction events in human T cells: a decrease
of 10–30% in the intracellular GSH content in peripheral
blood T lymphocytes has been shown to completely block
the TCR-stimulated elevation of cytoplasmic intracellular
free calcium ([Ca
 
2
 
1
 
]
 
i
 
; reference 18). The redox balance
GSH/GSSG is delicately regulated by the enzymes glu-
tathione peroxidase, which oxidizes GSH to GSSG, and
glutathione reductase, which catalyzes the reduction of
GSSG to GSH. A shift of the redox balance GSH/GSSG
towards a more prooxidant state by specific inhibition of
the enzyme glutathione reductase by BCNU (11), or alter-
natively by supplementation of cystine-free cultures with
GSSG, abolishes proliferation.
Addition of the antioxidant 2-ME to cystine-containing
culture medium fully substitutes for the costimulatory ca-
pacity of PB-MOs. 2-ME acts through the formation of
mixed disulfides with cysteine derived from extracellular
cystine (8). The 2-ME–cysteine mixed disulfide can be eas-
ily transported to lymphocytes via the membrane trans-
porter shared with leucine and phenylalanine (8). Upon in-
ternalization, this mixed disulfide requires intracellular
reduction to liberate cysteine. In contrast to lymphocytes,
mouse peritoneal macrophages were shown to have a
strong membrane transport activity for cystine (14). Mac-
rophages convert excess cystine to cysteine and secrete it
(14, 15), thereby increasing the glutathione content and
DNA synthesis in murine lymph node cells (15). Triggered
in part by CD2–CD58 interactions, human PB-MOs also
export cysteine. Our findings support the view that release
of this single chemically defined thiol compound enables
proliferation of TCR/CD3-activated LP-Ts. The redox
system responsible for intracellular reduction of cystine in
PB-MOs is not known. The GSH/GSSG system is not a
likely candidate, as we detected the release of large amounts
of cysteine even if glutathione synthesis and the enzyme
glutathione reductase were inhibited by BSO (12) and
BCNU (11), respectively.
Cross-linking of CD58 on PB-MO, mimicking multiva-
lent CD2 receptor binding, represents a signal for PB-
MOs, but not for LP-MOs, to release cysteine. The action
of the immobilized CD58 mAb was specific, as cross-link-
ing of CD54 using a mAb of the same Ig isotype or an iso-
type-matched control antibody failed to deliver cysteine.
Disruption of CD2–CD58 interactions decreased the stim-
ulatory capacity of PB-MOs by 
 
.
 
60%. This suggests that
additional as yet unknown receptor–ligand interactions or
cytokines other than IFN-
 
g
 
 could be involved.
Resident LP-MOs are not capable of releasing cysteine.
This finding could be explained by their low level expres-
sion of cell surface receptors involved in cysteine produc-
tion (CD14, CD58; reference 5). Alternatively, membrane
transport activity for cystine, intracellular reduction to cys-
teine, and export of cysteine might be intrinsically down-
regulated in LP-MOs. Thus, LP-MOs in normal gut may
contribute dually to “insufficient” costimulation of LP-Ts:
signals via CD2 are decreased by the lack of CD58 expres-
sion on LP-MOs, which in turn results in insufficient cys-
Figure 6. Thiol-dependent
proliferation of LP-T. (A) Cys-
tine-deficient RPMI 1640/10%
FCS was supplemented with
graded amounts of cystine at the
indicated final concentrations.
Concentration of 2-ME was 10
mM. Irradiated PB-MOs were
added at 30% of total cell num-
ber. (B) Stimulatory potential of
cysteine versus equimolar
amounts of cystine on the prolif-
eration of LP-Ts after CD3
(OKT3) or CD2 (M11M2)
stimulation. LP-Ts were plated
at 8 3 105/well in an initial vol-
ume of 1 ml/well in 24-well
plates. Cultures were primarily
set up in cystine-deficient me-
dium, and were supplemented
with cysteine in 15-ml volumes
every 6 h at a final concentration
of 30 mM each time. Cysteine had to be added repeatedly because of rapid oxidation to cystine under culture conditions. Alternatively, cultures received
equimolar amounts of cystine. After 84 h of culture, wells were pulsed with [3H]-TdR at 5 mCi/ml, and cells were harvested 18 h later.
 
Table I.
 
Influence of Reduced Versus Oxidized Glutathione on the 
Proliferation of LP-Ts in Cystine-deficient Medium
 
Unstim.
 
a
 
CD3 (OKT3)
 
a
 
CD2
(M1
 
1
 
M2
 
1
 
3PT)
LP-T 65 
 
6
 
 16 83 
 
6
 
 31 61 6 11
LP-T plus
GSH (3 mM) 298 6 38 27,830 6 2,241 56,143 6 5,226
LP-T plus
GSSG (1.5 mM) 72 6 14 78 6 20 90 6 34
Unstim., unstimulated.912 Redox Regulation of Lamina Propria T Lymphocytes
teine delivery for T cells. The low level expression of
CD14 on LP-MOs might also be important to secure local
T cell hyporesponsiveness in normal gut. The finding that
intestinal macrophages from normal gut, in contrast to
macrophages isolated from inflamed tissue in IBD, show
only minimal responsiveness to LPS as judged from pro-
duction of IL-1b (19), supports this notion.
This study may relate to the pathogenesis of IBD, where
macrophage populations in inflammatory sites with a differ-
ent phenotype than resident LP-MOs exist. The former
dominate in severely inflamed perivascular areas because of
a sustained recruitment of PB-MOs (20, 21), and could fa-
cilitate increased T cell proliferation in IBD (22) by means
of cysteine release. In contrast, resident LP-MOs in normal
gut may present antigen to LP-Ts but only insufficiently
deliver costimulatory signals, likely because of their inabil-
ity to release cysteine in association with low level CD54
and CD58 expression (5). Under conditions of excessive
antigenic stimulation, defective cysteine delivery by “non-
professional” APCs results in hyporesponsiveness of lym-
phocytes in vivo, whereas a cysteine-producing variant cell
line induces a successful immune response (23). Thus, the
differential capacity of PB-MOs and LP-MOs to release
cysteine evolves as a novel mechanism ensuring physiologi-
cal hyporesponsiveness of LP-T despite continous antigen
exposure in the normal intestinal microenvironment and,
in turn, increased lymphocyte reactivity in IBD.
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